Addressing gene therapy translational R&D bottlenecks in the CNS
Cell & Gene Therapy Insights 2023; 9(1), 181–185
Published: 9 March 2023
On February 2nd 2023, David McCall, Editor, Cell & Gene Therapy Insights, spoke to Anindya Sen, Executive Director, R&D at Prevail Therapeutics, about novel AAV capsid innovation and preclinical-clinical translation challenges in the CNS gene therapy space. This viewpoint has been written based on that interview.